Sexual Sadism With Lust-Murder Proclivities in a Female?
Dear Editor:
While there are sparse reports of sexually sadistic proclivities in females (1) (2) (3) , its most extreme subtype, lust-murder, has to my knowledge only been reported in male subjects (4) .
Case Report
A heterosexual woman in her late 20s was referred for a forensic psychological assessment to determine her fitness to stand trial on charges of arson. Her mother's pregnancy history, as well as her birth, growth and milestones, medical screening, and mental status exam all yielded unremarkable findings. Her psychological history unsheathed depressive episodes that resulted in trials of antidepressants, some self-reported episodes of panic attacks, and an episode of mania or hypomania that she had experienced 10 to 15 years earlier. She reported a psychosocial history that included a single incident of childhood sexual abuse and numerous incidences of physical violence against childhood peers, together with other antisocial behaviours (for example, truancy, fire setting, cruelty to animals, and some experimentation with substances). Further, she reported multiple paraphilic and fetishistic interests (for example, "men in diapers"); a personal study of sexual torture techniques; a history of adult homicidal ideation (that is, wanting to stab or shoot others); a captivation with, and admiration for, the most notorious serial homicidal criminals, along with a yearning to attain membership within that pantheon; the suppression of inordinate anger and hostility that was perennially at the point of exploding (for example, "feeling like a dormant volcano"), along with episodes of explosive dyscontrol; and an escalation of sadistic acts over time, culminating in meticulously planned, albeit thwarted, sexual homicides motivated by self-reported thrill seeking. A psychometric examination revealed prominent features of psychopathic personality disorder, with additional borderline features and negativistic features associated with an elevated potential for criminality. However, there was no evidence of a mood or thought disorder of any genre.
The patient's predatory sexual and homicidal proclivities involved a process of painstaking planning to murder young males toward whom she was sexually attracted. For example, she amassed photographic and informational files on her intended victims' daily schedules. In one case, she had planned to use a knife to kill a 13-year-old delivery boy after luring him to a secluded park; in another, she had planned the dispatch of a particular adult male musician.
This case appeared to clearly meet the DSM-IV "essential features" criteria for a sexually sadistic paraphilia (that is, recurrent, intense, sexually arousing fantasies and sexual urges or behaviours regarding the psychological or physical suffering or humiliation of others) (5) . It also exhibited correlates found among the more serious sexually sadistic and homicidal offenders (for example, fetishism). To my knowledge, this is the first description of a possible case of a lust-murder paraphilia in a female.
Larry C Litman, PhD, CPsych, FACAPP, FPPR, FSMI, FICPP London, Ontario
Topiramate-Induced Suicidality
Topiramate is a novel antiepileptic medication used as an adjunctive mood stabilizer in some patients with bipolar disorder (BD) (1) . Its association with appetite suppression and weight loss makes it appealing both to patients and to clinicians. Even though topiramate has been reported to be safe, psychiatric side effects in neurology (2) and BD (3) patients warrant caution. I describe a case of severe suicidal symptoms associated with topiramate in a BD patient.
Case Report
Ms Y, aged 41 years, has a 7-year history of BD. For the first 5 years, she did well on lithium carbonate. However, lithium was discontinued owing to intolerable dermatological conditions. She was taking carbamazepine 400 mg twice daily and levothyroxine 0.15 mg daily (for hypothyroidism) when topiramate was added as an adjuvant mood stabilizer and because of weight gain. The topiramate dosage was gradually increased to 50 mg 3 times daily. A few weeks after she had begun the 150-mg daily dosage of topiramate, Ms Y noticed the onset of sudden and severe suicidal symptoms. She had made her will and started putting her life in order, when her husband suspected a serious problem and brought her to our attention. She was obviously suffering from depression and admitted to planning to take her life. Topiramate was the only medication recently increased, and we were aware of its association with psychiatric symptoms. It was therefore stopped immediately, and Ms Y was closely monitored. Within a week, her mood stabilized: she become euthymic, and her suicidal symptoms cleared completely.
Among obese subjects with BD, the weight loss potential of topiramate may be beneficial and significant (4, 5) . Side effects, such as sedation, nausea, headache, dizziness, and cognitive effects, have been reported in 82% of BD patients taking topiramate, with 36% discontinuing treatment because of side effects (5) . Topiramate has also been associated with development of depressive and psychotic symptoms in patients with epilepsy and BD (2, 6) .
To my knowledge, this is the first report of severe suicidality associated with topiramate use in a patient with BD. Depression and suicidality are common features of mood disorder patients; however, the close temporal relation of newonset suicidal symptoms and the addition of topiramate, together with the speedy resolution after its discontinuation, highlight a possible relation between topiramate and the suicidal behaviour.
Topiramate has some usefulness in the management of psychiatric illness, especially when there is associated obesity. Nevertheless, clinicians should be aware that topiramate may be associated with the development of serious psychiatric symptoms, including severe suicidality, through a poorly understood mechanism that may involve multiple neurotransmitters.
G Abraham, MD, FRCPC Kingston, Ontario

Bright-Light Therapy in Somatization Disorder
The core features of somatization disorder are recurrent and multiple physical complaints that are not fully explained by physical factors and that result in medical attention or significant impairment. Somatization disorder (SD) is a chronic but fluctuating disorder that rarely remits completely. It is difficult to treat, and there appears to be no single superior treatment approach (1) . We report a case of SD treated with bright-light therapy.
Case Report
Ms K is a 39-year-old, married woman with a history of depression, SD, and 4 suicide attempts. She reported experiencing somatic complaints and depressive symptoms after she was married. She was treated for 4 years with tioridazine, alprazolam, and mirtazapine, until her last suicide attempt resulted in hospitalization. Her presenting symptoms were irritability, low mood, and frequent crying episodes. Additional somatic complaints were headache, low back pain, and dysmenorrhea. She was diagnosed with major depressive disorder (MDD) and SD according to DSM-IV criteria. Her cardiological, neurosurgical, neurological, gastroenterological, and ophthalmological examinations and routine laboratory examinations, including thyroid hormones, were all normal. She was started on a regimen of venlafaxine 150 mg daily and zopiclone 7.5 mg daily, as needed, for her sleep problems. On the fifteenth day, she continued to complain of somatic symptoms and long durations of sleep latency. Zopiclone was discontinued, and bright-light therapy was started. Light exposure was scheduled in the early morning because of her delayed sleep-wake pattern. We used a light box and an active lighttreatment condition of 10 000-lux white light for 30 minutes (Sadelite, Northern Light Technologies, Montreal, Quebec, Canada). We used the Visual Analog Scale (VAS) to measure her subjective somatic complaints, sleep, and appetite changes. After 2 weeks of light therapy, her Hamilton Depression Rating Scale (HDRS) score fell from 41 to 11. Her multiple subjective somatic complaints showed 80% to 90% improvement, and sleep latency shortened. We found no difference between morning and evening measurements of subjective complaints. She was discharged from the hospital
